ClinicalTrials.gg
CompletedNCT05811715Updated Apr 13, 2023

Effects of Whole-body Stretching Exercise for Reducing Musculoskeletal Pain and Physical Exertion Among Healthcare Professionals

An interventional study of whole body stretching excercise and educational program in Healthcare Professionals, sponsored by Najran University. Completed at 1 site in Saudi Arabia. Per ClinicalTrials.gov, last updated 2023-04-13.

Sponsored by Najran University · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Registered 4 months after the study started (first participant enrolled Nov 2022, registered Apr 2023).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Sex
All
01

Study summary

Purpose of the study:To investigate effect of whole-body stretching (WBS) exercise during lunch-break for reducing musculoskeletal pain and physical exertion among healthcare professionals

Read the detailed description

This study involved a single-blinded 2-arm randomized controlled trial (RCT) to compare the effect of WBS exercise versus control group during lunch-break to reduce symptoms of WRMSDs in healthcare professionals. sixty healthcare professionals were recruited from Najran university hospital, Saudi Arabia. Study objectives and procedure were properly explained and written informed consent was obtained at the beginning of the study. All the participants were randomly assigned into two equal groups A and B.

Group A were received the 30 minutes of whole body stretching class while group B were received an education program which includes ergonomic principles, WRMSDs and their risk factors, as well as manual handling techniques were explained .

02

Conditions studied

  • Healthcare Professionals
03

In context

Lead sponsor

Najran University is the lead sponsor of 7 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Full time healthcare professionals with more than one year of experience were eligible to participate

Exclusion criteria

Exclusion Criteria:

  • Acute musculoskeletal symptoms (pain intensity on visual analogue scale (VAS) > 7)
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
60 participants (actual)

Study arms

  • Experimental
    Group A

    WBS-Whole body stretching exercise group

    Other: whole body stretching excercise · Other: educational program

  • Active comparator
    Group B

    control group

    Other: educational program

Interventions

  • Otherwhole body stretching excercise

    For the WBS group, each 30 minutes exercise class was run by a one trained physiotherapist to serve a maximum of 10 participants (10 x 3 = 30 participants) working in the hospital. Participants invited to attend the exercise class 3 times a week for 6 weeks in their hospital during lunch-break. During each session, participants asked to perform WBS exercise (Franco et al., 2008).

  • Othereducational program

    Participants received an education program which includes ergonomic principles, WRMSDs and their risk factors, as well as manual handling techniques(Bolbol et al., 2017).

06

What researchers measure

Primary outcomes

  1. musculoskeletal pain

    musculoskeletal pain were assessed by Nordic musculoskeletal questionnaire

    Time frame: 6 Weeks

  2. physical exertion

    physical exertion were assessed by Borg rating of perceived exertion

    Time frame: 6 Weeks

07

Study locations

1 site
  • Hashim Ahmed
    Najrān, Najran 1988, Saudi Arabia
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Nov 2022 to primary completion in Mar 2023, 3 months.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 1, 2023
First posted
Apr 13, 2023
StartActual
Nov 16, 2022
Primary completionActual
Mar 15, 2023
CompletionActual
Mar 15, 2023
Last update
Apr 13, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 13, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05811715
Lead sponsor
Najran University
Responsible party
Hashim Ahmed (Assistant Professor, Najran University) — Principal investigator
First posted
Apr 13, 2023
Start date
Nov 16, 2022
Primary completion
Mar 15, 2023
Completion
Mar 15, 2023
Last update
Apr 13, 2023

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion